Literature DB >> 11950703

Opposite effects of plasma from human apolipoprotein A-II transgenic mice on cholesterol efflux from J774 macrophages and Fu5AH hepatoma cells.

Natalie Fournier1, Anne Cogny, Véronique Atger, Danièle Pastier, Dominique Goudouneche, Antonino Nicoletti, Nicole Moatti, Jean Chambaz, Jean-Louis Paul, Athina-Despina Kalopissis.   

Abstract

Overexpression of human apolipoprotein A-II (hapo A-II) in transgenic mice (hAIItg mice) induced marked hypertriglyceridemia and low levels of plasma high density lipoprotein (HDL) with a high hapo A-II content. We sought to determine whether cholesterol efflux to plasma and HDL from these mice would be affected. In the Fu5AH cell system, plasma from hAIItg mice induced a markedly lower cholesterol efflux than did control plasma, in accordance with the dependence of efflux on HDL concentration. Moreover, HDLs from hAIItg mice were less effective acceptors than were control HDLs. In the J774 macrophage cell system, pretreatment with cAMP, which upregulates ATP binding cassette transporter 1, induced a marked increase in the efflux to hAIItg plasma as well as to purified hapo A-I and hapo A-II, whereas it had no effect on cholesterol efflux to control plasma. A strong positive correlation was established between percent cAMP stimulation of efflux and plasma hapo A-II concentration. The cAMP stimulation of efflux to hAIItg mouse plasma may be linked to the presence of pre-beta migrating HDL containing hapo A-II. Thus, despite lower HDL and apolipoprotein A-I contents, the increased ability of plasma from hAIItg mice to extract cholesterol from macrophage-like cells may have an antiatherogenic influence.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11950703     DOI: 10.1161/01.atv.0000013023.11297.b2

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  6 in total

1.  Human apolipoprotein A-II protects against diet-induced atherosclerosis in transgenic rabbits.

Authors:  Yao Wang; Manabu Niimi; Kazutoshi Nishijima; Ahmed Bilal Waqar; Ying Yu; Tomonari Koike; Shuji Kitajima; Enqi Liu; Tomohiro Inoue; Masayuki Kohashi; Yuka Keyamura; Tomohiro Yoshikawa; Jifeng Zhang; Loretta Ma; Xiaohui Zha; Teruo Watanabe; Yujiro Asada; Y Eugene Chen; Jianglin Fan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-12-13       Impact factor: 8.311

2.  Phospholipids mediated conversion of HDLs generates specific apoA-II pre-beta mobility particles.

Authors:  Malgorzata Wróblewska; Barbara Kortas-Stempak; Andrzej Szutowicz; Tadeusz Badzio
Journal:  J Lipid Res       Date:  2008-12-09       Impact factor: 5.922

3.  Apolipoprotein A-I mimetic peptide helix number and helix linker influence potentially anti-atherogenic properties.

Authors:  Geoffrey D Wool; Catherine A Reardon; Godfrey S Getz
Journal:  J Lipid Res       Date:  2008-03-05       Impact factor: 5.922

4.  The effect of weight loss on HDL subfractions and LCAT activity in two genotypes of APOA-II -265T>C polymorphism.

Authors:  Masoumeh Moradi; Maryam Mahmoudi; Ahmad Saedisomeolia; Roxana Zahirihashemi; Fariba Koohdani
Journal:  Nutr J       Date:  2017-05-25       Impact factor: 3.271

5.  Large-Scale Analysis of Determinants, Stability, and Heritability of High-Density Lipoprotein Cholesterol Efflux Capacity.

Authors:  Andrea L Koekemoer; Veryan Codd; Nicholas G D Masca; Christopher P Nelson; Muntaser D Musameh; Bernhard M Kaess; Christian Hengstenberg; Daniel J Rader; Nilesh J Samani
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-08-31       Impact factor: 8.311

Review 6.  Current Understanding of the Immunomodulatory Activities of High-Density Lipoproteins.

Authors:  Athina Trakaki; Gunther Marsche
Journal:  Biomedicines       Date:  2021-05-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.